KR100877492B1 - 엽산을 함유하는 연질캡슐제 조성물 및 그의 제조방법 - Google Patents
엽산을 함유하는 연질캡슐제 조성물 및 그의 제조방법 Download PDFInfo
- Publication number
- KR100877492B1 KR100877492B1 KR1020070041062A KR20070041062A KR100877492B1 KR 100877492 B1 KR100877492 B1 KR 100877492B1 KR 1020070041062 A KR1020070041062 A KR 1020070041062A KR 20070041062 A KR20070041062 A KR 20070041062A KR 100877492 B1 KR100877492 B1 KR 100877492B1
- Authority
- KR
- South Korea
- Prior art keywords
- folic acid
- soft capsule
- present
- mixed
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
용출시간 (분) | 용출률(%) | ||||||
비교예4 | 실시예1 | 실시예2 | 실시예3 | 실시예4 | 실시예5 | 실시예6 | |
5 | 25.3 | 30.1 | 29.2 | 27.3 | 22.8 | 16.7 | 33.3 |
10 | 49.9 | 62.3 | 60.3 | 50.2 | 48.2 | 40.3 | 64.3 |
15 | 70.9 | 84.8 | 80.3 | 71.9 | 78.6 | 65.4 | 87.3 |
30 | 85.0 | 95.7 | 92.3 | 87.9 | 88.2 | 83.6 | 91.3 |
경과 시간 (개월) | 함량(%) | |||||||||
비교예1 | 비교예2 | 비교예3 | 비교예4 | 실시예1 | 실시예2 | 실시예3 | 실시예4 | 실시예 5 | 실시예 6 | |
0 | 100.3 | 100.4 | 100.5 | 100.1 | 100.2 | 100.1 | 100.8 | 100.6 | 100.0 | 100.4 |
1 | 95.3 | 97.1 | 100.2 | 99.9 | 100.1 | 99.9 | 98.3 | 98.4 | 99.8 | 100.0 |
2 | 92.5 | 95.5 | 100.3 | 100.3 | 100.0 | 99.9 | 97.3 | 98.6 | 99.6 | 100.2 |
4 | 89.3 | 92.3 | 100.4 | 100.3 | 100.2 | 100.3 | 96.4 | 98.3 | 99.8 | 99.3 |
6 | 85.1 | 91.1 | 99.8 | 100.2 | 100.1 | 100.1 | 95.1 | 97.9 | 98.7 | 99.4 |
구분 | 6개월 가속조건 | ||||||||
비교예1 | 비교예2 | 비교예3 | 실시예1 | 실시예2 | 실시예3 | 실시예4 | 실시예 5 | 실시예 6 | |
성상변화 | - | - | - | - | - | - | - | - | - |
침전유무 | +++ | ++ | - | - | - | - | - | - | - |
붕해시간 | 15min | 37min | 40min | 13min | 18min | 16min | 20min | 22min | 16min |
Claims (3)
- 엽산 함유 연질캡슐제에 있어서,연질캡슐제의 내용약물은 내용약물 전체중량대비 프로필렌글리콜과 폴리에틸렌글리콜의 혼합 용제 99.57 중량%,엽산 0.33 중량%, 그리고디에탄올아민 0.1 중량%를 포함하며,상기 연질 캡슐제의 내용약물은 투명한 것을 특징으로 하는 엽산 함유 연질캡슐제.
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070041062A KR100877492B1 (ko) | 2007-04-27 | 2007-04-27 | 엽산을 함유하는 연질캡슐제 조성물 및 그의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070041062A KR100877492B1 (ko) | 2007-04-27 | 2007-04-27 | 엽산을 함유하는 연질캡슐제 조성물 및 그의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080096095A KR20080096095A (ko) | 2008-10-30 |
KR100877492B1 true KR100877492B1 (ko) | 2009-01-09 |
Family
ID=40155518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070041062A KR100877492B1 (ko) | 2007-04-27 | 2007-04-27 | 엽산을 함유하는 연질캡슐제 조성물 및 그의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100877492B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220109499A (ko) | 2021-01-27 | 2022-08-05 | 주식회사 킥더허들 | 4세대 활성형 엽산 조성물 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004123636A (ja) | 2002-10-03 | 2004-04-22 | Nof Corp | 二重被覆造粒物およびその製造方法 |
US20040081681A1 (en) | 2002-10-25 | 2004-04-29 | Jacob Vromen | Formulations for topical delivery of bioactive substances and methods for their use |
US20040156895A1 (en) | 2002-11-12 | 2004-08-12 | Elan Pharma International Ltd. | Solid dosage forms comprising pullulan |
KR20050019198A (ko) * | 2003-08-18 | 2005-03-03 | 한국유나이티드제약 주식회사 | 가용성 덱시부프로펜의 연질캅셀제 조성물 및 그의 제조방법 |
US20050101561A1 (en) | 2003-11-07 | 2005-05-12 | Tunac Josefino B. | HDL-boosting combination therapy complexes |
KR20050071890A (ko) * | 2004-01-05 | 2005-07-08 | 신일제약주식회사 | 이부프로펜과 아르기닌 함유 고농축 액상 조성물 및연질캡슐제 |
KR20050092626A (ko) * | 2004-03-16 | 2005-09-22 | 주식회사 디피아이 솔루션스 | 수상에서 비타민 c 및 그 유도체를 안정화시키기 위한조성물 및 이를 이용한 비타민 c 및 그 유도체의 안정화방법 |
-
2007
- 2007-04-27 KR KR1020070041062A patent/KR100877492B1/ko active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004123636A (ja) | 2002-10-03 | 2004-04-22 | Nof Corp | 二重被覆造粒物およびその製造方法 |
US20040081681A1 (en) | 2002-10-25 | 2004-04-29 | Jacob Vromen | Formulations for topical delivery of bioactive substances and methods for their use |
US20040156895A1 (en) | 2002-11-12 | 2004-08-12 | Elan Pharma International Ltd. | Solid dosage forms comprising pullulan |
KR20050019198A (ko) * | 2003-08-18 | 2005-03-03 | 한국유나이티드제약 주식회사 | 가용성 덱시부프로펜의 연질캅셀제 조성물 및 그의 제조방법 |
US20050101561A1 (en) | 2003-11-07 | 2005-05-12 | Tunac Josefino B. | HDL-boosting combination therapy complexes |
KR20050071890A (ko) * | 2004-01-05 | 2005-07-08 | 신일제약주식회사 | 이부프로펜과 아르기닌 함유 고농축 액상 조성물 및연질캡슐제 |
KR20050092626A (ko) * | 2004-03-16 | 2005-09-22 | 주식회사 디피아이 솔루션스 | 수상에서 비타민 c 및 그 유도체를 안정화시키기 위한조성물 및 이를 이용한 비타민 c 및 그 유도체의 안정화방법 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220109499A (ko) | 2021-01-27 | 2022-08-05 | 주식회사 킥더허들 | 4세대 활성형 엽산 조성물 |
Also Published As
Publication number | Publication date |
---|---|
KR20080096095A (ko) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW420607B (en) | Rapamycin pharmaceutical compositions for oral administration | |
TW461812B (en) | Rapamycin-containing pharmaceutical composition for oral administration | |
JP4890732B2 (ja) | 癌治療用パクリタキセル・リポソーム組成物およびその製造方法 | |
CA2549966A1 (en) | Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle | |
WO1999027946A1 (en) | Pharmaceutical composition comprising cyclosporin solid-state microemulsion | |
CN104661648A (zh) | 阿片样物质制剂 | |
JP2014098039A (ja) | 生物学的利用能を向上した医薬組成物 | |
EP3041512A2 (en) | Fulvestrant compositions | |
JP2014098045A (ja) | インドリノン誘導体の即時放出のための医薬投薬形態 | |
CN103070871A (zh) | 一种氟维司群的药物组合物 | |
CN106924172A (zh) | 一种石杉碱甲溶致液晶制剂及其制备方法 | |
KR100877492B1 (ko) | 엽산을 함유하는 연질캡슐제 조성물 및 그의 제조방법 | |
US20140073670A1 (en) | Pharmaceutical composition comprising fexofenadine | |
CN103054799B (zh) | 一种盐酸胺碘酮注射乳剂及其制备方法 | |
CN113440499B (zh) | 叶酸口溶膜剂及其制备方法 | |
JP2009501796A (ja) | 睡眠薬の放出調整 | |
CN110856746B (zh) | 一种含卡非佐米的胶束冻干制剂及其制备方法 | |
KR100588771B1 (ko) | 실리마린 함유 약학적 조성물 및 이를 함유하는 연질 캅셀 | |
KR100558070B1 (ko) | 가용성 덱시부프로펜의 연질캅셀제 조성물 및 그의 제조방법 | |
KR101234253B1 (ko) | 안정성이 향상된 경구용 엽산 연질캡슐제 | |
TW202128150A (zh) | 3'—[(2z)—[1—(3,4—二甲基苯基)—1,5—二氫—3—甲基—5—側氧基—4h—吡唑—4—亞基]肼基]—2'—羥基—[1,1'—聯苯基]—3—甲酸及其鹽配製物 | |
KR100561317B1 (ko) | 아미노산 및 아테놀올을 함유하는 투명 연질 캡슐 | |
CN111603439A (zh) | 一种长效依匹哌唑原位相变凝胶注射剂及其制备方法 | |
KR20190093999A (ko) | 용해성 및 안정성이 향상된 덱시부프로펜 시럽제제 | |
KR100588810B1 (ko) | 글리메피리드를 가용화시켜 투명 내용액으로 함유한연질캅셀제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121017 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20131120 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20141201 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20151102 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170111 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20171222 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20191023 Year of fee payment: 12 |